Why you should say "NO" to sex the night before your PSA test...

and other things you probably don't know about your prostate health, but should!

  • No matter what your prostate problem may be...
  • No matter if you've been diagnosed with prostate cancer...
  • Even if you think your prostate's just fine for now...

Here's vital information you simply can't afford to ignore.

Prostate Disorders White Paper Cov

The 2018 Prostate Disorders White Paper

Your Annual Guide to Prevention, Diagnosis and Treatment

Did you know...

  • Having sex within 72 hours of your PSA test can produce a false reading?
  • ED can be a symptom of prostate cancer?
  • By age 70, the average man's prostate has doubled in size.
  • Early detection of prostate cancer is a KEY factor in treating this disease successfully.
  • Being fully informed is also importantóand that's where the 2018 Prostate Disorders White Paper comes in.

It's your all-in-one comprehensive guide for everything you need to know about your prostate. From what it is and what it does, to what problems can develop and what to watch out for.

You'll learn

  • Key facts about prostate health.
  • The warning signs and symptoms that could alert you that something might be wrong.
  • The latest treatments you never knew existed.
  • How to understand what your options are if you're ever diagnosed with prostate cancer or another prostate condition common to men as they grow older.

The 2018 Prostate Disorders White Paper is published as a means of sharing everything we know about conditions of the prostate in significant depth, yet in layman's language.

Prostate disorders experts and doctors review the major medical journals, clinical trials and research studies, and bring this cutting-edge health information straight to you.

Introducing Your Prostate Disorders Expert

H. Ballentine Carter, M.D., is Professor of Urology and Oncology and the Director of Adult Urology at the Johns Hopkins University School of Medicine. He has written extensively on the diagnosis and staging of prostate cancer. In particular, he has performed research on the prostate-specific antigen (PSA) test: how results change as men age; the variability of results in men with prostate cancer; and the test's use in staging, predicting and managing prostate cancer. He recently chaired the American Urological Association guideline panel that made recommendations for prostate cancer diagnosis.

Dr. Carter leads one of the largest active surveillance programs in the United States to monitor men with prostate cancer who do not need immediate treatment. Results from this program have been used to inform guidelines for the management of men with early prostate cancer. Dr. Carter has had research articles published in a number of publications, including The Journal of Urology, Urology, Cancer Research, the Journal of the American Medical Association (JAMA), the Journal of Clinical Oncology and the Journal of the National Cancer Institute.

You won't find a more comprehensive, authoritative and reliable source than this for the vital information every man must have!

Highlights of the 2018 Prostate Disorders White Paper include:

  • The pros and cons of prostate cancer treatment options including: active surveillance, radical prostatectomy, external beam radiation therapy (EBRT), and brachytherapy.
  • Prostate cancer screening has saved thousands of lives. However, over the past decade or so, men have been bombarded with mixed messages about the value of the most effective tool for early detection of prostate canceróthe PSA test. These messages can make it difficult to determine how to balance the benefits and risks. We look at the recent PSA testing recommendations in order to help you decide who needs one, when to get it, and how often.
  • Prostate cancer is highly heritable, meaning that a manís genetic profile greatly affects his odds of developing the disease. In fact, researchers recently discovered that defects, or mutations, in certain genes that normally play a maintenance role in the body increase the risk for metastatic prostate cancer, the variety thatís hardest to treat. This research has important implications for men with advanced prostate canceróand for their families as well.
  • Do you really need a DRE? Find out why some doctors say itís indispensable, but others arenít so sure.
  • Find out what you can do if an initial screening result suggests prostate cancer.
  • The most important factor in predicting the current state of a manís prostate cancer and determining his treatment options is his Gleason score. Learn how a biopsy Gleason score is determined and a better way to explain and understand what this critical diagnostic tool really means.
  • Some treatment guidelines suggest that active surveillance may be an option for certain men with intermediate-risk prostate cancer, although the practice is controversial. To provide clarification, researchers analyzed data from more than 6,700 men who had undergone a radical prostatectomy. Find out what the study supports.

But that's not all. You'll also find "Ask the Doctor" columns in the 2018 Prostate Disorders White Paper, posing the same questions that are on your mind now as you're trying to make the best decisions possible about your prostate health, including a look at whether or not testosterone supplements increase the risk for prostate cancer. We know that testosterone promotes the growth of prostate cells and that blocking this naturally occurring hormone can help control the growth of prostate cancer. But there is great controversy over whether using testosterone supplements increases a manís risk for prostate cancer. Read more about this in the 2018 Prostate Disorders White Paper.

You'll get all this cutting edge information in the 2018 Prostate Disorders White Paper (PLUS your free Health Tips Prostate Power) for the one low price of only $19.95 plus shipping. Order now and download the digital edition right away AND we'll mail you the print edition of the White Paper. This way you get the benefit of having both the print and digital editions. Best of all, this offer is risk-free. Your copy of the 2018 Prostate Disorders White Paper comes with a full money-back guarantee if you're not satisfied for any reason.

The new, updated 2018 Prostate Disorders White Paper is designed to help you become better informed and better prepared to deal with whatever prostate problem you may have now, or may develop in the future.

You'll learn to ...

  • Recognize and respond to symptoms and changes as they occur.
  • Communicate effectively with your doctor, ask informed questions and understand the answers.
  • Make the right decisions, based on an understanding of the newest drugs, the latest surgical techniques and the most promising research.
  • Take control over your condition and act from knowledge rather than fear.

In this White Paper, you'll receive ...

  • A thorough overview of the prostate condition, its causes and symptoms ...
  • Treatment options with an expert recommendation on each ...
  • Groundbreaking new research and a review of the latest studies ...
  • Drugs used to treat the condition, with precautions on avoiding harmful side effects ...
  • A glossary of medical terms you need to understand ...
  • A listing of health information organizations and support groups ...
    ... and more.

In the 2018 Prostate Disorders White Paper, you'll learn:

  • Key facts about your prostate, what it is and the role it plays in your overall health.
  • The signs and symptoms that something might be wrong.
  • How prostate cancer is diagnosed; what you need to know about:
    • The pros and cons of a PSA Test
    • The Digital Rectal Exam (DRE)
    • Your Prostate Biopsy and Gleason Score
    • The newest tests for diagnosing prostate cancer more accurately than ever before.
  • The latest treatment options available to you if you have prostate cancer, an enlarged prostate or prostatitis.
  • Prostate disease prevention strategies.
  • Key research and studies on prostate cancer and BPH (also known as BPE).
  • Where to get further support and resources.

Why worry about my prostate health now?

"Why worry about my prostate health now?" you might ask. Some experts believe that every man will develop some degree of prostate cancer if he lives long enough. Autopsy studies have shown microscopic evidence of prostate cancer in 15-30 percent of men over the age of 50 and in 60-70 percent of men who reach age 80.

But don't let that statistic scare you. The reality is that fewer men are dying from prostate cancer than ever before.

And the next generation's risk is decreasing all the time. New statistics tell us that a male born today has a 16 percent chance of being diagnosed with prostate cancer at some time in his life, but just a 3 percent chance of dying from the disease.

But that's not all! Order now, and you'll also receive this
FREE Health Tips as an instant download:

Health and Wellness Tips Cover

FREE Prostate Disorders Health Tips:

Prostate Power: What Men Must Know NOW

Prostate Power is yours free just for ordering the 2018 Prostate Disorders White Paper. In this invaluable Health Tips, you'll find answers to crucial questions like:

  • Are you at risk for prostate cancer?
  • Knowing the facts will help you protect your prostate.
  • Getting a second (or third or fourth) opinion.
  • Getting a balanced view of all your treatment options for prostate cancer.
  • Finding help for sexual function problems.
  • A visit to a urologist or mental health professional may benefit your sex life.
  • When you see blood in your urine.
  • This alarming sign has a variety of possible causes, and not all of them are serious.

All this, and much, much moreóProstate Power is yours free and available as an instant PDF download when you purchase the 2018 Prostate Disorders White Paper.

If you've recently been diagnosed with prostate cancer, you'll find the 2018 Prostate Disorders White Paper to be an invaluable resource for understanding and evaluating your treatment options.

You'll receive detailed descriptions of the three most common treatments: radical prostatectomy, external beam radiation therapy and brachytherapy. Understand what they are, how they are performed and the advantages and disadvantages of each.

You'll also learn whether your PSA and Gleason score make you a candidate for active surveillance so you can maintain a high quality of life without the often irreversible side effects of certain prostate cancer treatments.

You'll learn the most common side effects of each of the prostate cancer treatments detailed in this comprehensive White Paper.

You'll understand how doctors predict the seriousness of a cancer diagnosis, and how you can work in conjunction with your doctor to know all your options and decide which treatment is best for you.

You'll even learn how your doctor determines the extent of your cancer, and what the treatments and prognosis are for each stage of prostate cancer.

All in the 2018 Prostate Disorders White Paperóavailable to order now

  • Learn what it means when you have to get up frequently at night to urinate ...
  • What it means when it hurts to urinate or ejaculate ...
  • Why your persistent lower back pain may be due to your prostate, rather than back strain or injury ...

Rely on the 2018 Prostate Disorders White Paper to help you understand:

  • How prostate problems and treatments can affect sexual function ...
  • The three kinds of prostate trouble ...
  • The different kinds of prostatitis ...
  • What actually causes an enlarged prostate ...

Study the detailed color illustrations and comprehensive charts and tables in the 2018 Prostate Disorders White Paper, including:

  • An up-to-date 2018 chart of medications used in the treatment of benign prostatic enlargement, including information on how the drugs work, special instructions for taking the medications and possible side effects.
  • An illustrated chart of the stages of prostate cancer. This chart explains the TNM staging system used to describe a cancer's clinical stage, or how far it has spread.
  • A chart of prostate cancer mortality rates 10, 15 and 20 years after radical prostatectomy.
  • An up-to-date 2018 listing of all medications used in the treatment of advanced prostate cancer.
  • The NCCN Risk Classification and Management chart that's used by physicians to help choose the correct prostate cancer treatment.

And these are just the highlights. Each chart and illustration is designed to help you gain a greater understanding of the vital information presented in the 2018 Prostate Disorders White Paper, so you can make the best decisions about your health care.

SPH logo

University of California, Berkeley,
School of Public Health

The White Papers are published by the University of California, Berkeley, School of Public Health. These publications are an outgrowth of the Schoolís commitment to help improve the health and wellness of our community of readers by publishing expert advice on prevention, diagnosis and treatment for a wide range of ailments and disorders. We provide trusted, authoritative health guidance from leading physicians and researchers at Americaís top medical centers and hospitals.

The School of Public Health is
consistently rated among the best in the nation

The faculty, consistently noted as among the leading scholars in their respective fields, comprises approximately 150 investigators. Among our faculty are Institute of Medicine members, American Association for the Advancement of Science fellows, Fulbright fellows, and National Academy of Sciences members. The School enrolls approximately 575 graduate students a year, as well as educating about 425 undergraduate students through the upper-division public health major. The School's more than 15,000 graduates can be found working throughout the world, both in the public and private sectors.

The School of Public Health, believes that everyone,
everywhere, has the right to a healthy life

Your purchase of the Prostate Disorders White Paper supports the School of Public Health faculty and students in their work to confront the major health challenges of our generation. A portion of every sale goes to funding scholarships. Your purchase will directly benefit your own health as well as those in your community.

You can count on the White Papers to bring you medical information that is trustworthy, impeccably researched and current.

Still not convinced you want to order
the Prostate Disorders White Paper risk-free?

Then take this test ...

  • TRUE OR FALSE: Prostate cancer has a stronger hereditary component than breast and colon cancers.
  • TRUE OR FALSE: Lifestyle choices may be able to modify the effects of the genetic cards you are dealt at birth.
  • TRUE OR FALSE: Deaths from prostate cancer vary from region to region in the U.S.
  • TRUE OR FALSE: The most reliable way to detect prostate cancer in its early stages is to combine digital rectal exams with PSA testing.
  • TRUE OR FALSE: Doctors believe that the overall PSA level may be less important than the rate at which the PSA level rises.

Okay, let's see how you did. The answer to each of these questions is TRUE. Each question is taken from the pages of the 2018 Prostate Disorders White Paper. In it, you'll also learn what you can do to help protect yourself from prostate cancer:

  • Exercise helps, especially in older men. Learn how men 65 and older were able to reduce their risk of advanced prostate cancer by nearly 70 percent.
  • Foods that may reduce your risk of prostate cancer.
  • How excess weight can contribute to prostate cancer progression.

It's all in the 2018 Prostate Disorders White Paper. Don't hesitate. Take advantage of this risk-free opportunity. Order now.

We're so sure that this is crucial health information no man should do without that we are offering you the 2018 Prostate Disorders White Paper absolutely risk-free for 30 days. Your satisfaction is 100 percent guaranteed, or your money back.

Just click the order button to take advantage of this unique offer. You'll receive both a link to download the digital edition to read now AND we'll mail the print edition of the 2018 Prostate Disorders White Paper to explore and examine risk-free. You'll also receive your link to download your free Health Tips! You'll receive both the digital and the print editions for $19.95 plus shipping.

If for any reason you are not completely satisfied with your White Paper, you may return it within your 30-day preview period. But keep Prostate Power: What Men Must Know NOW as your free digital report "Thank You" gift just for reviewing the 2018 Prostate Disorders White Paper.

Our no-strings, can't lose, must-be-satisfied guarantee

You don't risk a penny to take a good, long look at the 2018 Prostate Disorders White Paper. You must be 100 percent convinced this is essential information you can't do without, or you may return it within your 30-day preview period.

Frankly, it's hard to imagine how anyone with prostate issues would part with this information from leading medical experts. But you decide once you see it.

Just click below to receive both the print and digital editions of the 2018 Prostate Disorders White Paper. Keep the free gift even if you decide, for any reason, to return your White Paper.

To keep you on the cutting edge of prostate research, we offer an automatic annual update service to White Paper readers. That way, your White Paper is always current, never out of date.

A card will be sent to you in advance and if you wish to examine the next year's White Paper, do nothing and it will arrive automatically with an invoice. If you don't wish to see the new Prostate Disorders White Paper, simply return the card within 30 days. You may notify us at any time if you don't want to continue in the program.

If you've just been diagnosed with prostate cancer ...

If you've been struggling with prostate cancer treatments and their side effects ...

If you're having problems urinating, or you're doing it too often at night ...

If you're not sure if you should have your PSA levels tested ...

Even if you're sure your prostate's doing just fine ...

This urgent information belongs in your hands without another minute's delay.